AIMC Topic: United States Food and Drug Administration

Clear Filters Showing 71 to 80 of 92 articles

Regulatory Issues and Challenges to Artificial Intelligence Adoption.

Radiologic clinics of North America
Artificial intelligence technology promises to redefine the practice of radiology. However, it exists in a nascent phase and remains largely untested in the clinical space. This nature is both a cause and consequence of the uncertain legal-regulatory...

Machine Learning: The Next Paradigm Shift in Medical Education.

Academic medicine : journal of the Association of American Medical Colleges
Machine learning (ML) algorithms are powerful prediction tools with immense potential in the clinical setting. There are a number of existing clinical tools that use ML, and many more are in development. Physicians are important stakeholders in the h...

Conflicting information from the Food and Drug Administration: Missed opportunity to lead standards for safe and effective medical artificial intelligence solutions.

Journal of the American Medical Informatics Association : JAMIA
The Food & Drug Administration (FDA) is considering the permanent exemption of premarket notification requirements for several Class I and II medical device products, including several artificial Intelligence (AI)-driven devices. The exemption is bas...

Unexpected Inequality: Disparate-Impact From Artificial Intelligence in Healthcare Decisions.

Journal of law and health
Systemic discrimination in healthcare plagues marginalized groups. Physicians incorrectly view people of color as having high pain tolerance, leading to undertreatment. Women with disabilities are often undiagnosed because their symptoms are dismisse...

Addressing health disparities in the Food and Drug Administration's artificial intelligence and machine learning regulatory framework.

Journal of the American Medical Informatics Association : JAMIA
The exponential growth of health data from devices, health applications, and electronic health records coupled with the development of data analysis tools such as machine learning offer opportunities to leverage these data to mitigate health disparit...

Regulatory oversight, causal inference, and safe and effective health care machine learning.

Biostatistics (Oxford, England)
In recent years, the applications of Machine Learning (ML) in the health care delivery setting have grown to become both abundant and compelling. Regulators have taken notice of these developments and the U.S. Food and Drug Administration (FDA) has b...

Machine Learning Uncovers Food- and Excipient-Drug Interactions.

Cell reports
Inactive ingredients and generally recognized as safe compounds are regarded by the US Food and Drug Administration (FDA) as benign for human consumption within specified dose ranges, but a growing body of research has revealed that many inactive ing...